NCT04801004View on ClinicalTrials.gov

A Real-world Study to Evaluate the Primary Patency and Freedom From TLR of Endovascular Treatment in TOSAKA III In-stent Restenosis of Lower Extremity Femoropopliteal Artery.

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Peripheral Arterial Disease
Trial Locations (1)

Unknown

Zhongshan Hospital, Fudan University, Shanghai

All Listed Sponsors
collaborator

RenJi Hospital

OTHER

collaborator

First Affiliated Hospital of Zhejiang University

OTHER

collaborator

Chengdu University of Traditional Chinese Medicine

OTHER

collaborator

Xuanwu Hospital, Beijing

OTHER

collaborator

First People's Hospital of Hangzhou

OTHER

collaborator

Qingdao Hiser Medical Group

OTHER

collaborator

Second Affiliated Hospital of Soochow University

OTHER

collaborator

Liyuan Hospital of Tongji Medical College of Huazhong University of Science and Technology

UNKNOWN

lead

Shanghai Zhongshan Hospital

OTHER